Stefanos Theoharis

Stefanos Theoharis is an accomplished executive with extensive expertise in the biotechnology and life sciences sectors, currently serving as the Chief Executive Officer at OneChain Immunotherapeutics and as a Venture Partner at Deep Science Ventures since July 2020. With a strong background in cell and gene therapies, immunotherapy, and corporate development, Stefanos has held significant roles including Managing Director at Venture Advanced Therapies and Chief Business Officer at BONE THERAPEUTICS S.A. Previous positions include SVP Corporate Development at Cell Medica, CBO at apceth, and Head of Business Development at Antisense Pharma, among others, where responsibilities encompassed strategic planning, alliance management, and transaction execution. Stefanos holds a PhD in Cell & Gene Therapy and has a solid educational foundation in Molecular Medicine and Biology from prestigious institutions such as Imperial College London and Royal Holloway, University of London.